Bausch Health Companies | VRX - الأصول





الأصول تغيير تاريخ
Amgen USD 92.5B 1.92B 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bausch Health Companies USD 24.79B 296M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Drreddys Laboratories INR 579.35B 573.08B 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novo Nordisk DKK 559.22B 16.32B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03
Zoetis USD 15.15B 313M 2026-03